Drug · DIN 02459655
OTIXAL
SINGLE-USE VIALS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 25, 2023; first marketed May 8, 2017.
- Drug Identification Number (DIN)
- 02459655
- Company (DIN owner)
- Medexus Pharmaceuticals Inc.Bolton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Otic
- Therapeutic class (ATC)
- Fluocinolone acetonide and antiinfectives S02CA05
- Class
- Human
- Record last updated
- August 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) | 0.3 % | W/V |
| FLUOCINOLONE ACETONIDE | 0.025 % | W/V |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 25, 2023: NOC 29981New Drug Submission (NDS) · Administrative: Change in Product Ownership
- June 15, 2020: NOC 23786New Drug Submission (NDS) · Administrative: Merger/Buy-out
- December 8, 2016: NOC 18739New Drug Submission (NDS)